Cargando…

Feasibility of detecting atrophy relevant for disability and cognition in multiple sclerosis using 3D-FLAIR

BACKGROUND AND OBJECTIVES: Disability and cognitive impairment are known to be related to brain atrophy in multiple sclerosis (MS), but 3D-T1 imaging required for brain volumetrics is often unavailable in clinical protocols, unlike 3D-FLAIR. Here our aim was to investigate whether brain volumes deri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noteboom, Samantha, van Nederpelt, D. R., Bajrami, A., Moraal, B., Caan, M. W. A., Barkhof, F., Calabrese, M., Vrenken, H., Strijbis, E. M. M., Steenwijk, M. D., Schoonheim, M. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576669/ https://www.ncbi.nlm.nih.gov/pubmed/37466663 http://dx.doi.org/10.1007/s00415-023-11870-4

Ejemplares similares

Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis
por: van Lierop, Zoë YGJ, et al.
Publicado: (2022)

Reliability of brain atrophy measurements in multiple sclerosis using MRI: an assessment of six freely available software packages for cross-sectional analyses
por: van Nederpelt, David R., et al.
Publicado: (2023)

Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy
por: Steenwijk, Martijn D., et al.
Publicado: (2017)

Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light
por: Wessels, Mark HJ, et al.
Publicado: (2023)

Gray matter networks and cognitive impairment in multiple sclerosis
por: Rimkus, Carolina M, et al.
Publicado: (2018)

Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method
por: Popescu, Veronica, et al.
Publicado: (2016)

The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis
por: Lie, Ingrid Anne, et al.
Publicado: (2022)

Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple Sclerosis
por: Loonstra, Floor C., et al.
Publicado: (2022)

FLAIR-only joint volumetric analysis of brain lesions and atrophy in clinically isolated syndrome (CIS) suggestive of multiple sclerosis
por: Goodkin, O., et al.
Publicado: (2020)

Long-range connections are more severely damaged and relevant for cognition in multiple sclerosis
por: Meijer, Kim A, et al.
Publicado: (2020)

The role of diet in multiple sclerosis onset and course: results from a nationwide retrospective birth‐year cohort
por: Loonstra, Floor C., et al.
Publicado: (2023)

Histopathology-validated recommendations for cortical lesion imaging in multiple sclerosis
por: Bouman, Piet M, et al.
Publicado: (2020)

Damage in the Thalamocortical Tracts is Associated With Subsequent Thalamus Atrophy in Early Multiple Sclerosis
por: Weeda, Merlin M., et al.
Publicado: (2020)

Accurate white matter lesion segmentation by k nearest neighbor classification with tissue type priors (kNN-TTPs)()
por: Steenwijk, Martijn D., et al.
Publicado: (2013)

Cognitive and Clinical Dysfunction, Altered MEG Resting-State Networks and Thalamic Atrophy in Multiple Sclerosis
por: Tewarie, Prejaas, et al.
Publicado: (2013)

A randomized trial predicting response to cognitive rehabilitation in multiple sclerosis: Is there a window of opportunity?
por: Prouskas, Stefanos E, et al.
Publicado: (2022)

DeepGRAI (Deep Gray Rating via Artificial Intelligence): Fast, feasible, and clinically relevant thalamic atrophy measurement on clinical quality T2-FLAIR MRI in multiple sclerosis
por: Dwyer, Michael, et al.
Publicado: (2021)

Relationship Between White Matter Lesions and Gray Matter Atrophy in Multiple Sclerosis: A Systematic Review
por: Lie, Ingrid Anne, et al.
Publicado: (2022)

Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis
por: Vrenken, H., et al.
Publicado: (2012)

The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis
por: Lie, Ingrid Anne, et al.
Publicado: (2022)

Predicting clinical progression in multiple sclerosis after 6 and 12 years
por: Dekker, I., et al.
Publicado: (2019)

Utility of coronal contrast-enhanced fat-suppressed FLAIR in the evaluation of optic neuropathy and atrophy
por: Boegel, Kevin H., et al.
Publicado: (2017)

Repair what is lost: Neuroprotection through neural stem cells in progressive MS
por: Schoonheim, Menno M., et al.
Publicado: (2023)

Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients
por: van Lierop, ZYGJ, et al.
Publicado: (2021)

Quantitative FLAIR MRI in Amyotrophic Lateral Sclerosis
por: Fabes, Jeremy, et al.
Publicado: (2017)

Revisiting Brain Atrophy and Its Relationship to Disability in Multiple Sclerosis
por: Shiee, Navid, et al.
Publicado: (2012)

Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase study
por: Barnett, Michael, et al.
Publicado: (2021)

Artificial double inversion recovery images for (juxta)cortical lesion visualization in multiple sclerosis
por: Bouman, Piet M, et al.
Publicado: (2021)

Real-world keystroke dynamics are a potentially valid biomarker for clinical disability in multiple sclerosis
por: Lam, KH, et al.
Publicado: (2020)

Non-linear registration improves statistical power to detect hippocampal atrophy in aging and dementia
por: Bartel, F., et al.
Publicado: (2019)

Validation of mean upper cervical cord area (MUCCA) measurement techniques in multiple sclerosis (MS): High reproducibility and robustness to lesions, but large software and scanner effects
por: Weeda, M.M., et al.
Publicado: (2019)

Lesion detection at seven Tesla in multiple sclerosis using magnetisation prepared 3D-FLAIR and 3D-DIR
por: de Graaf, Wolter L., et al.
Publicado: (2011)

Automatic segmentation and volumetry of multiple sclerosis brain lesions from MR images
por: Jain, Saurabh, et al.
Publicado: (2015)

Smartphone‐derived keystroke dynamics are sensitive to relevant changes in multiple sclerosis
por: Lam, Ka‐Hoo, et al.
Publicado: (2021)

Explaining the heterogeneity of functional connectivity findings in multiple sclerosis: An empirically informed modeling study
por: Tewarie, Prejaas, et al.
Publicado: (2018)

Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study
por: Lie, Ingrid Anne, et al.
Publicado: (2022)

FLAIR* to visualize veins in white matter lesions: A new tool for the diagnosis of multiple sclerosis?
por: Campion, T., et al.
Publicado: (2017)

Plasma proteome in multiple sclerosis disease progression
por: Malekzadeh, Arjan, et al.
Publicado: (2019)

Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers
por: Coric, Danko, et al.
Publicado: (2017)

T2 mapping outperforms normalised FLAIR in identifying hippocampal sclerosis
por: Rodionov, R., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ihcarf7817aompf9vebb7043mb